Ranbaxy Laboratories, one of the leading
pharma players, recovered on value buying on Tuesday after a sharp
fall in previous session. Earlier on Monday,shares of the company
plunged 30% after the US Food and Drug Administration (USFDA)
issued import alert on the company's Mohali unit.
Shares of the company settled at Rs
328.75, up Rs 9.9, or 3.10% at the Bombay Stock Exchange (BSE) on
Tuesday.The scrip has touched an intra-day high of Rs 338.90 and
low of Rs 320. The total volume of shares traded at the BSE is
2,536,081.In the earlier session, the shares declined 30.27%, or Rs
138.4, at Rs 318.85.Currently, the stock is trading down 41.27%
from its 52-week high of Rs 559.80 and above 29.45% over the
52-week low of Rs 253.95.
Share Price Movement Period Pricein Rs
Gain/(Loss) in Rs in % 1 Week 378.15 (28.70) (7.59) 1 Month 393.15
(43.70) (11.12) 3 Months 431.80 (82.35) (19.07) 6 Months 504.00
(154.55) (30.66) 1 Year 488.55 (139.10) (28.47) Note: Based on
previous day closing price.